The ETS gene products are a family of transcriptional regulatory proteins that contain a highly conserved and structurally unique DNA binding domain, termed the ETS domain. Several ETS proteins bind to DNA as monomers, however it has been shown that the DNA binding activity is enhanced or modulated in the presence of other factors. By dierential display and whole genome PCR techniques, we have recently shown that the Erg1 gene is a target for ETS proteins. The Egr1 promoter contains multiple ETS binding sites, three of which exist as parts of two serum response elements (SREI and SREII). The SRE is a cis-element that regulates the expression of many growth factor responsive genes. ELK1 and SAP1a have been shown to form ternary complexes with SRF on the SRE located in the cfos promoter. Similarly, we examined whether the ELK1, SAP1a, FLI1, EWS-FLI1, ETS1, ETS2, PEA3 and PU.1 proteins can form ternary complexes with SRF on the Egr1 SREI and II. Our results demonstrate that indeed ELK1, SAP1a, FLI1 and EWS-FLI1 are able to form ternary complexes with SRF on Egr1 SREs. In addition, ELK1 and SAP1a can also form quarternary complexes on the Egr1 SREI. However, the proteins ETS1, ETS2, PEA3 and PU.1 were unable to form ternary complexes with SRF on either the Egr1 or c-fos SREs. Our data demonstrate that FLI1 and EWS-FLI1 constitute new members of a subgroup of ETS proteins that can function as ternary complex factors and further implicate a novel function for these ETS transcription factors in the regulation of the Egr1 gene. By amino acid sequence comparison we found that, in fact, 50% of the amino acids present in the B-box of SAP1a and ELK1, which are required for interaction with SRF, are identical to those present in both FLI1 (amino acids 231 ± 248) and EWS-FLI1 proteins. This B-box is not present in ETS1, ETS2, PEA3 or PU.1 and these proteins were unable to form ternary complexes with SRF and Egr1-SREs or cfos SRE. Furthermore, deletion of 194 amino terminal amino acids of FLI1 did not interfere with its ability to interact with SRF, in fact, this truncation increased the stability of the ternary complex. The FLI1 protein has a unique R-domain located next to the DNA binding region. This R-domain may modulate the interaction with SRF, providing a mechanism that would be unique to FLI1 and EWS-FLI1, thus implicating a novel function for these ETS transcription factors in the regulation of the Egr1 gene.
Introduction
The ETS family of proteins are important transcriptional regulators and contain a highly-conserved DNAbinding domain Nye et al., 1992; Watson et al., 1988) . Members of the ETS gene family have been characterized and identi®ed in a broad range of animal species, including Drosophila, sea urchin, Xenopus, avian, murine and humans (Janknecht and Nordheim, 1993; Seth et al., 1992; Wasylyk et al., 1993; Watson et al., 1990) . The ETS family genes include: vets, ETS1, ETS2, ERG, ELK1, PEA3, SAP1a, Spi-1/ PU.1, GABPa (E4TF1-60), ER71, ER81, FLI1 (which we designated as ERGB, Watson et al., 1992) , ELF, TEL, ERP, PE1, ERF, sea urchin ETS and Erg and Drosophila E74, D-Ets2/pointed, D-ets3, D-ets4, DEts6, D-elg and D-yan/pok (Bhat et al., 1996) .
The ETS DNA-binding domain consists of 85 amino acids and recent NMR analysis of this domain reveals a novel topography containing three a-helices and a four-stranded b-sheet, forming a helix ± turn ± helix structure (Donaldson et al., 1994; Liang et al., 1994; Werner et al., 1995) . The ETS proteins bind to a purine-rich core sequence located in many gene promoter and enhancer sequences (Seth et al., 1993a (Seth et al., , 1994 Watson et al., 1992) . The consensus ETS binding site (EBS) contains a -GGAA/T-core sequence¯anked by dierent nucleotides that determine the anity and speci®city of binding for a particular ETS protein Seth et al., 1993a Seth et al., , 1994 . The ETS proteins are able to bind to DNA either directly or, in certain cases, DNA-binding activity of an ETS protein can be augmented or stabilized in the presence of speci®c antibody (Seth et al., 1993b) or other protein factors (Dalton and Treisman, 1992; La Marco et al., 1991) .
The ETS family of transcription factors play important roles during murine embryogenesis. During mouse development ETS1 mRNA is associated with bone formation in vertebrae, tails and limbs (Kola et al., 1993; Maroulakou et al., 1994) . ETS2 is expressed in newly forming cartilage, including in the skull precursor cells and vertebral primordia. Overexpression of the ETS2 gene in transgenic mice resulted in Down's syndrome-like skeletal abnormalities (Sumarsono et al., 1996) .
The ETS gene products induce cellular transformation and are involved in neoplasia. Overexpression of ETS1 and ETS2 genes has been shown to transform mouse and rat ®broblasts in culture and induce tumors in nude mice Seth et al., 1989; Topol et al., 1992) . The FLI1 gene is found to be fused in-frame to the EWS gene at the breakpoint of translocation t(11 : 22) which is frequently found in Ewing sarcomas and peripheral neuroectodermal tumors (Delattre et al., 1992) . The chimeric (EWS-FLI1) protein product contains the amino terminal region of EWS (a potential RNA-binding protein) fused with the carboxy terminal DNA binding domain of FLI1 protein. This chimeric protein is able to transform cells and induces tumors in nude mice (Lessnick et al., 1995; May et al., 1993) . Although the chimeric protein binds to the same EBS, it exhibits much higher transactivation activity than the fulllength FLI1 protein (Bailly et al., 1994; Mao et al., 1994; May et al., 1993; Ohno et al., 1993) .
In our continuing eort to investigate the mechanisms that control transcriptional regulation and target selection by ETS proteins, we have utilized whole genome PCR and dierential display techniques to identify and clone promoters/enhancers containing functional ETS binding sites (EBS) that are required for the proper induction (or repression) of the target gene. We found that both of these methods identi®ed the Egr1 gene as an ETS target (Robinson et al., 1995) . Egr1 is an early growth response gene (also known as NGF1-A, zif268 and Krox-24) that was originally identi®ed by its rapid induction in response to various growth factors (Christy et al., 1988) . Interestingly, when overexpressed in v-sis transformed NIH3T3 cells, Egr1 was able to suppress tumor growth in nude mice (Huang et al., 1994) . The Egr1 promoter contains multiple ETS binding sites; in fact, many of the ETS binding sites are located adjacent to the CArG boxes and constitute the serum response elements (SRE). The expression of the Egr1 gene is controlled by SREs clustered in its promoter region. Two of the SRE motifs in the Egr1 promoter are required for elevated expression during monocyte dierentiation (Kharbanda et al., 1994) , and these sites are also necessary for the induction of Egr1 expression during B-cell activation (McMahon and Monroe, 1995) . The transcriptional induction of several genes in response to serum growth factors is elicited, in part, by the formation of a ternary complex with SRF on the SRE situated within their promoters. The ternary complex contains the SRE, serum response factor (SRF) and one of several ternary complex factors (TCF) (Treisman, 1994) . ELK1 and SAP have been shown to form a ternary complex on the c-fos promoter (Hipskind et al., 1991; Price et al., 1995) . Herein we present evidence that in addition to ELK1 and SAP1a, FLI1 and EWS-FLI1 proteins can also form ternary complexes on the Egr1 SREs. We also show that ELK1 and SAP1a can form quarternary complexes on the Egr1 SREI.
Results
In order to isolate novel ETS target genes, we performed ETS1 binding with MboI cleaved genomic DNA followed by whole genome PCR and isolated various promoter/enhancer fragments that bind to the ETS1 protein. The bound DNA fragments were ampli®ed and subcloned into plasmid vectors and subjected to DNA sequence and computer analysis. One of the clones we isolated was found to contain DNA sequences derived from the regulatory regions of the human EGR1 gene. Interestingly, the mouse Egr1 gene was also identi®ed as an ETS target by dierential display between control cell-lines and transfectants that express high levels of ETS1 (Robinson et al., 1995) .
Binding of FLI1 protein to the Egr1 EBS
The mouse Egr1 promoter contains several ETS binding sites (Figure 1 ). Two of them are located at position 7414 and 7393 which¯ank a CArG box (SREI). A third site is located at position 792; this EBS is¯anked by two CArG boxes (SREII). We synthesized oligonucleotides corresponding to these two sites and examined their binding with recombinant ETS proteins by electrophoretic mobility shift assays (EMSAs). The ETS1 protein binds to both the Egr-SREI and Egr-SREII oligonucleotides (Robinson et al., 1995) . To examine whether other members of the ETS family will also bind to these sites, we used recombinant FLI1 protein expressed in insect cells. This protein binds speci®cally to both the Egr-SREI and Egr-SREII oligonucleotides ( addition of the unlabeled oligonucleotides (lanes 2 and 5). Similarly, the addition of monoclonal antibody speci®c for FLI1 produces supershifted complexes (lanes 3 and 6), which are abrogated with the addition of excess unlabelled probes (data not shown). Although the ETS1 protein binds with equal eciency to both the single EBS Egr-SREII and dual EBS containing Egr-SREI sites (data not shown), the FLI1 shows much higher anity for the dual EBS containing site present in Egr-SREI.
FLI1, EWS-FLI1, ELK1 and SAP1a form ternary complexes with SRF on the Egr1 SREI and SREII ELK1 and SAP1a have been shown to form ternary complexes with SRF on the c-fos SRE. To determine whether FLI1 and EWS-FLI1 can funtion as TCFs, we examined their ability to form ternary complexes with SRF on the c-fos SRE. We found that although EWS-FLI1 is able to form a weak ternary complex, the FLI protein was unable to form a complex ( Figure 3a) .
We also examined whether these ETS proteins can form ternary complexes on the Egr1 SREI and SREII. Our results show that FLI1, EWS-FLI1, ELK1 and SAP1a proteins are able to interact with SRF on both the Egr1-SREI and Egr1-SREII sites (Figure 3b and c). In addition, each of these proteins is able to form a strong binary complex with the Egr1-SREI site ( Figure  3c ). No such strong binary complex is observed with cfos-SRE and Egr1-SREII (Figure 3a and b). Although ETS1, ETS2, PEA3 and PU.1 proteins are able to form a binary complex on Egr1-SREI, they are unable to interact with SRF to form a ternary complex (data not shown).
ELK1 and SAP1a form ternary complexes with SRF on the Egr1-SREII and c-fos SRE. On the Egr1-SREI, ELK1 and SAP1a form ternary and quaternary complexes, while FLI1 or EWS-FLI1 form only a ternary complex. Formation of a quaternary complex is due to the presence of two EBS sequences located in Egr1-SREI which is in contrast to the single EBS present in c-fos and Egr1-SREII. These data further suggest that the mechanism of ternary and quaternary complex formation with ELK1 and SAP1 on the Egr1-SREI is fundamentally dierent than the c-fos and Egr1-SREII complex. In addition, ELK1 and SAP1a bind dierently than did the EWS-FLI1 and FLI1 on the Egr1-SREI site.
Speci®c interaction of FLI1 and EWS-FLI1 with SRF on Egr1-SREI
To determine the speci®city of protein-DNA complexes, we performed EMSAs in the presence of various competing oligonucleotides (Figure 4a ). The wild type SREI oligonucleotide inhibits the formation of both binary and ternary complex formation with SRF as well as with FLI1 and EWS-FLI1 (lanes 2, 6, 10, 14 and 18). Competition with excess EBS (lacking a CArG box) inhibits the formation of a binary complex with FLI1 and EWS-FLI1 (lanes 3 and 19), as well as inhibiting the ternary complex (lanes 7 and 15). Incubation in the presence of an SREI oligonucleotide containing a mutation in the CArG box (SRE M ) is able to block the formation of binary complexes with FLI1 or EWS-FLI1 (lanes 4 and 20) and inhibits the ternary complex formation (lanes 8 and 16). Our data provide evidence that ternary complex formation by FLI1 and EWS-FLI1 requires both wild type SRE and SRF protein.
Subsequently we performed binding assays using constant amounts of SRF and increasing amounts of either FLI1 or EWS-FLI and vice versa. The results, shown in Figure 4b , demonstrate that increasing amounts of either SRF or ETS proteins, result in an increase in ternary complex formation. Moreover, increasing amounts of SRF eects a further decrease in the FLI1 : Egr-SREI and EWS-FLI : SREI binary complexes, suggesting that these interactions are speci®c, and that the ternary complex is being generated by FLI : SRF : Egr1-SREI and EWS-FLI1 : SRF : Egr1-SREI interactions. Similarly, increasing amounts of SRF protein in the presence of constant ELK1 protein results in a signi®cant increase in ternary and quaternary complex formation and a reduction in the ELK1 : DNA complex (data not shown).
Dierential contribution of EBS sequences to the formation of the ternary and quaternary complexes
To determine the relative contribution of the two EBS sequences present in the Egr1-SREI to the binding by ETS proteins and to the formation of ternary and quaternary complexes in the presence of SRF protein, we synthesized several oligonucleotides having mutations in each of the EBS sequences ( Figure 1 EMSA were done using either Egr-SREI or Egr-SREII labeled oligonucleotides in the presence (lanes 2 and 5) and absence (1, 3, 4 and 6) of excess unlabeled oligonucleotide. Supershift analysis was done with 2 mg of a speci®c monoclonal antibody (lanes 3 and 6) (Zhang et al., 1995) which is seen with the wild type Egr1-SREI (LR) oligonucleotide (compare lanes 2 and 4 with lanes 7 and 9). In contrast ELK1 and to a lesser extent, SAP1a are able to form ternary and quaternary complexes (lanes 12 and 14) when the mutation is in the 3' EBS (LR M ). Signi®cantly, the interaction of FLI1 and EWS-FLI1 (Figure 5b ) with Egr1 SREI is unaected by mutation of the 3' EBS ((LR M ) compare lanes 5 and 8; lanes 14 and 17). In contrast, the ability to bind directly to the SRE or to form a ternary complex in the presence of SRF protein is completely abolished by mutation in the 5' EBS (L M R). Collectively, from these data, it can be concluded that the 5' EBS site present in the SREI is critical for the formation of ternary complexes for ELK1, SAP1a, EWS-FLI, and FLI1, and quaternary complex formation by ELK1 and SAP1a.
Localization of the FLI1 domain required for interaction with SRF ELK1 and SAP1a contain three regions of sequence similarity: (1) the amino-terminal DNA binding domain: (2) a region (the B-box) that is necessary for proteinprotein interaction with SRF and (3) a region near the carboxy-terminus (C box) which contains regulatory sites for phosphorylation by MAP kinase. Amino acid sequence alignment of FLI1 (amino acids 231 ± 248) with the B-boxes of SAP1a and ELK1 reveals signi®cant homology in that region (Figure 6a ). This region of FLI1 is also retained in the majority of EWS-FLI1 chimeric proteins. A deletion variant of the FLI1 protein (FLI1 (BC)), lacking the 194 amino terminal amino acids, but retaining the B box homology region, was examined for its ability to form a ternary complex on the Egr1 SREI and SREII. Although FLI1(BC) is not able to form a binary complex, it is able to form ternary complexes on the Egr1-SREI and SREII (Figure 6b, lanes 6 and 13) . It is likely that the FLI1 and EWS-FLI1 proteins interact with SRF through B-box sequences in a manner similar to ELK1 and SAP1a. The FLI1(BC) proteins forms a stronger complex than the full length FLI1 protein, suggesting that the amino-terminal end in the FLI1 protein contains sequences than can inhibit complex formation.
Discussion
By dierential display and whole genome PCR technologies we have identi®ed the Egr1 gene promoter as a target for the ETS1 and FLI1 transcription factors (Robinson et al., 1995) . Egr1 is an early growth response gene containing several serum response elements (SRE) in its promoter region. Transcriptional induction of several genes including c- -3 3  3  3  3  6  9  3  3  6 9  -3  3  3  3  3 6  9  -3  3  3  -----------------3  3 fos in response to serum growth factors is elicited by the formation of a ternary complex on the SRE located within its promoter region. The ternary complex is formed by the SRE sequence, the SRF protein, and one of the ETS proteins such as ELK1 or SAP1a that are able to function as ternary complex factors (TCF).
In this report we examined whether in addition to ELK1 and SAP1a, six other ETS factors, FLI1, EWS-FLI1, ETS1, ETS2, PEA3 and PU.1, are able to function as TCF on c-fos and Egr1 SREs. Our results demonstrated that ELK1, SAP1a, FLI1 and EWS-FLI1 can indeed interact eciently with the SRF on Egr1 SREI and ELK1, SAP1a and EWS-FLI1 can also form ternary complexes with SRF on the Egr1 SREII and c-fos SRE sequences. Although the FLI1 protein forms a ternary complex with SRF on the Egr1 SREI, it is unable to form a ternary complex with the SRF on the c-fos SRE. On the other hand the ETS family   -2  2  2  --2  2  2  --2  2  2  -2 2  ---2  2  ---2  2  ------2  2  ---2  2  ---2 Figure 5 Interaction of ETS proteins with the SRF on wild type or mutant Egr1-SREI sites. Gel shift assays were done with ELK1 and SAP1a (a) or FLI1 and EWS-FLI1 (b) using labeled wild type (LR) or mutant (L M R, LR M ) oligonucleotides, as indicated above the lanes (see Figure 1 for sequences) members like ETS1, ETS2, PEA3 and PU.1 do not form ternary complexes with SRF on both the Egr1 and c-fos SREs. Thus, our study demonstrates that FLI1 and EWS-FLI1 are additional members of the ETS gene family proteins that can function by formation of ternary complex factors on SREs of various promoters.
EWS-EWS-EWS-
We have shown that the two SREs located in the Egr1 promoter are targets for transcriptional regulation via binding by ETS family proteins. However, there are dierential preferences in the ETS family targeted-binding to these SREs. Speci®cally the distal SRE element appears to bind more eciently than does the proximal SRE site. The distal SRE, in the Egr1 promoter region, contains one CArG box¯anked by two ETS boxes (Egr1-SREI), whereas the proximal SRE contains an ETS box¯anked by two CArG boxes (Erg1-SREII). In addition, these ETS boxes contain dierent nucleotides¯anking the GGAA core sequence. In SREI, the left ETS box (CCGGAA) contains two C residues 5' to the core, which creates an optimal ETS1, FLI1, ELK1 and SAP1a binding site. On the other hand the right ETS box (CAGGAA) in SREI and the single ETS box (CAGGAA) in SREII are not¯anked by the optimal nucleotides which are known to be recognized by ETS1, FLI1, ELK1 and SAP1a therefore the binding at these two sites is observed to be weaker. Further, in support of these observations, mutation analysis shows that FLI1 and EWS-FLI1 bind only to the 5' ETS box of the distal Egr1-SREI site, whereas oligonucleotides with wild type sequences or mutation in the 3' ETS box have equivalent binding activities.
We have shown that ELK1, SAP1a, FLI1 and EWS-FLI1 proteins interact with SRF and, dependent upon the nucleotide sequences of the SREs, may form ternary or quaternary complexes (Figure 7) . EWS-FLI1 formed a ternary complex with all three SREs, Egr1-SREI, Egr1-SREII and c-fos SRE. FLI1 formed a strong ternary complex with Egr1 SREI and a weak ternary complex with Egr1 SREII. ELK1 and SAP1a generated ternary complexes with Egr1-SREII and c-fos SRE, and formed both ternary and quaternary complexes with Egr1-SREI (Figure 7) . The unique ability of ELK1 and SAP1a proteins to form quaternary complexes on SRE elements having more than one EBS, supports the idea that the DNA binding speci®city of ETS proteins plays a role in de®ning target selection to a subset of serum response elements. It is therefore quite likely to generalize that SREs having dierent¯anking sequences will be transcriptionally activated by distinct TCF proteins, thereby further conferring tissue speci®city by this molecular variation. By amino acid sequence comparison we found that, in fact, many of the amino acid sequences present in the B box of SAP1a and ELK1, which is the region that has been shown to interact with SRF, are identical to those present in both FLI1 (aa 231 ± 248) and EWS-FLI1. However, this B-box is not present in ETS1, ETS2, PEA3 and PU.1 and these proteins are therefore unable to form ternary complexes with SRF and Egr1-SREI or SREII. Thus, it is very likely that FLI1 and EWS-FLI1 interact with SRF in this region. Furthermore, deletion of 194 aminoterminal amino acids of FLI1 does not interfere with its ability to interact with SRF because it still retains the B-box region (aa 231 ± 248). In fact, this truncation signi®cantly increases the stability of the ternary complex suggesting that the N-terminal domain (aa 1-194) may exert inhibitory action on the DNA binding domain of FLI1. The FLI1 protein has a unique region (R domain) located next to the DNA binding domain, that is also conserved in sea urchin, mouse and human erg-related genes Qi et al., 1992) . This domain may modulate the interaction with SRF, providing a mechanism that would be unique to FLI1 and EWS-FLI1.
Ewing's sarcoma is associated with the translocation t(11 : 22) which results in production of a chimeric EWS-FLI1 protein. In the hybrid protein, the Nterminal transactivation domain of EWS, an RNA binding protein, is fused in-frame with the FLI1 DNA binding domain.
The chimeric EWS-FLI1 protein has biological activities dierent from both EWS or FLI1. The FLI1 does not transform cells; whereas, the chimeric EWS-FLI1 protein exhibits high transforming activity. In addition, EWS-FLI is more ecient than FLI1 in transcriptional activation of dierent gene promoters (May et al., 1993; Lessnick et al., 1995) . Since the normal FLI1 transactivation domain has been substituted with the EWS N-terminal domain, the fusion protein may be unable to activate a number of wildtype FLI1 target genes and activate others more eciently. In some instances EWS-FLI1 may even inappropriately activate a new set of genes resulting in marked growth alteration and cellular transformation. The Egr1 gene appears to have a critical function in the regulation of multiple developmental pathways. This role was ®rst hypothesized based upon the elevated Egr1 expression observed during mitogenic stimulation of ®broblasts (Christy et al., 1988) , B-cell maturation and in the dierentiation of nerve (Milbrandt, 1987) , bone (Suva et al., 1991) , and myeloid cells (Coleman et al., 1992; Nguyen et al., 1993) . Similar to a regulatory role demonstrated for various ETS genes, Egr1 is also involved in B-and T-cell maturation (Perez-Castillo et al., 1993) . Further support for such an inter-relationship between ETS proteins and Egr1 is provided by the observation that both Ets1 and Egr1 gene products are upregulated upon dierentiation of P19 cells into neural-type derivatives with retinoic acid (Kola et al., 1993; Sukhatme et al., 1988) .
From the data we have presented, it appears that the Egr1 gene is responsive to ETS transcription factors in an SRF independent or dependent manner by a speci®c TC formation that depends upon the type of ETS factors bound. The ability of TCFs to bind to SRE elements in the absence of SRF protein is dependent upon the¯anking sequences present in the ETS boxes. For example, ELK1 is unable to bind to the SRE present in the c-fos promoter in the absence of SRF (see Figure 3a and (Hipskind et al., 1991) ). Similar to the results we describe for the SRFindependent binding of ELK1 to the Egr1 SREI (Figure 3c ), ELK1 has been shown by others to be able to bind (independently of SRF) to the SRE of the pip92 gene (Latinkic and Lau, 1994) . The SRE elements in the Egr1 promoter are critical for speci®c cellular responses (McMahon and Monroe, 1995) . The distal SRE element (Egr1-SREI) is required for induction of Egr1 during monocytic dierentiation (Kharbanda et al., 1994) , as well as in B-cell maturation (McMahon and Monroe, 1995) . Similarly the proximal SRE (Egr1-SREII) is important for NGF induction in PC12 (DeFranco et al., 1993) and cytokine induction (Sakamoto et al., 1994) . Such selective utilization of dierent Egr1 SRE elements may, in part, be due to the speci®c ETS family (ELK1, SAP1, FLI1 or EWS-FLI1) transcription factor present and thus contributes to the formation of the ternary and/or quaternary complexes in regulating Egr1 gene expression.
Materials and methods

Recombinant proteins
The recombinant ETS1 and FLI1 proteins were obtained from SF-9 cells using ETS1 or FLI1 gene-containing baculoviral vectors. In addition, ETS1 and FLI1 as well as SAP1a, ELK1 and SRF, were produced in vitro using the Promega rabbit reticulocyte system. The SAP1a, ELK1 and SRF plasmids were generously provided by Dr R Treisman. FLI(BC) was expressed in E coli using the HisTag expression vector, courtesy of Dr Constance Fisher. The ETS1 and FLI monoclonal antibodies were produced in mice using bacterially-expressed products (Koizumi et al., 1990; Zhang et al., 1995) .
Electrophoretic mobility shift assay
The proteins utilized in gel retardation assays were either obtained from SF-9 cells or prepared in vitro using the rabbit reticulocyte system. The protein : DNA interactions were performed using a 32 P-labeled, puri®ed doublestranded probe (50 000 c.p.m.) containing the Egr1SREI and Egr1SREII sequences (Figure 1 ). 1 mg of SF-9 nuclear extract or 5 ml of in vitro translated proteins were incubated at 48C. After 20 min the protein : DNA complexes were analysed on a non-denaturing 4% polyacrylamide gel containing 0.256TBE; the gel was dried and subjected to autoradiography (Seth et al., 1993b) .
Cloning of the EWS-FLI chimeric cDNA from the HTB166 cell line
The EWS-FLI1 chimeric gene was ampli®ed with sense (AGAGGGAGACGGACGTTG) and antisense (AGGC-CACATATGTCCTGT) primers using cDNA prepared from the HTB166 cell line mRNA. The ampli®ed EWS-FLI fragment was subcloned in pBS SK + and pSG5 vectors (Stratagene). The DNA sequence of the EWS/FLI junction was determined by the dideoxy chain termination method and found to disrupt the FLI1 protein between amino acids 197 and 198.
